Haematopoiesis, Stem cell factor, Bone marrow, Molecular biology and Cancer research are his primary areas of study. His Haematopoiesis study frequently draws connections between related disciplines such as Cellular differentiation. The concepts of his Stem cell factor study are interwoven with issues in Cell type and Immunology.
Feng Chun Yang has included themes like Progenitor cell, GTPase and Cdc42 GTP-Binding Protein in his Bone marrow study. His biological study spans a wide range of topics, including Guanosine, Endocrinology and Internal medicine, Lymphocyte. His study in Cancer research is interdisciplinary in nature, drawing from both Tumor suppressor gene, Neurofibromin 1 and Mast cell.
His main research concerns Cancer research, Haematopoiesis, Bone marrow, Immunology and Cell biology. His Cancer research research includes elements of Neurofibromin 1, Leukemia and Pathogenesis. His studies examine the connections between Haematopoiesis and genetics, as well as such issues in Progenitor cell, with regards to CD34.
His Bone marrow research is multidisciplinary, relying on both Molecular biology, Endocrinology, Mesenchymal stem cell and Transplantation. His research integrates issues of Myelopoiesis and FANCG in his study of Immunology. Feng Chun Yang mostly deals with Stem cell factor in his studies of Cell biology.
Feng Chun Yang mainly investigates Cancer research, Haematopoiesis, Myeloid, Myeloid leukemia and Leukemia. Feng Chun Yang interconnects Pathogenesis, Mutation, Apoptosis, Stem cell and Bone marrow in the investigation of issues within Cancer research. His Haematopoiesis study integrates concerns from other disciplines, such as Progenitor cell, Epigenetics and Immunology.
His research in Immunology intersects with topics in Regulator and Myelopoiesis. Feng Chun Yang has included themes like Cancer, Transcription factor, Gene mutation, CD34 and CARM1 in his Myeloid study. His research in Myeloid leukemia intersects with topics in Histone, Drug resistance and Decitabine.
His primary scientific interests are in Haematopoiesis, Myeloid leukemia, Cancer research, Myeloid and Leukemia. His work on Haematopoiesis is being expanded to include thematically relevant topics such as Progenitor cell. His Myeloid leukemia research also works with subjects such as
In his study, Cord blood is strongly linked to Bone marrow, which falls under the umbrella field of Myeloid. His biological study deals with issues like Stem cell, which deal with fields such as Regeneration and Cytokine. His Immunology research incorporates themes from Tyrosine kinase, Drug resistance and Kinase activity.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies.
Zhe Li;Xiaoqiang Cai;Chen Leng Cai;Jiapeng Wang.
Blood (2011)
Collection, Cryopreservation, and Characterization of Human Dental Pulp–Derived Mesenchymal Stem Cells for Banking and Clinical Use
Brandon C. Perry;Dan Zhou;Xiaohua Wu;Feng Chun Yang.
Tissue Engineering Part C-methods (2008)
Nf1-Dependent Tumors Require a Microenvironment Containing Nf1+/−- and c-kit-Dependent Bone Marrow
Feng Chun Yang;David A. Ingram;Shi Chen;Yuan Zhu.
Cell (2008)
Rac and Cdc42 GTPases control hematopoietic stem cell shape, adhesion, migration, and mobilization
Feng-Chun Yang;Simon J Atkinson;Ying Gu;Ying Gu;Jovencio B Borneo;Jovencio B Borneo.
Proceedings of the National Academy of Sciences of the United States of America (2001)
Rac2 stimulates Akt activation affecting BAD/Bcl-XL expression while mediating survival and actin function in primary mast cells.
Feng Chun Yang;Reuben Kapur;Alastair J. King;Wen Tao.
Immunity (2000)
Leptin stimulates the proliferation of murine myelocytic and primitive hematopoietic progenitor cells
Yumi Umemoto;Kohichiro Tsuji;Kohichiro Tsuji;Feng Chun Yang;Feng Chun Yang;Yasuhiro Ebihara;Yasuhiro Ebihara.
Blood (1997)
Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/– mast cells
Feng Chun Yang;David A. Ingram;Shi Chen;Cynthia M. Hingtgen.
Journal of Clinical Investigation (2003)
Genetic and Biochemical Evidence That Haploinsufficiency of the Nf1 Tumor Suppressor Gene Modulates Melanocyte and Mast Cell Fates in Vivo
David A. Ingram;Feng Chun Yang;Jeffrey B. Travers;Mary Jo Wenning.
Journal of Experimental Medicine (2000)
Stimulation of mouse and human primitive hematopoiesis by murine embryonic aorta-gonad-mesonephros-derived stromal cell lines.
Ming Jiang Xu;Kohichiro Tsuji;Kohichiro Tsuji;Takahiro Ueda;Takahiro Ueda;Yoh Suke Mukouyama;Yoh Suke Mukouyama.
Blood (1998)
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial
Kent A. Robertson;Grzegorz Nalepa;Feng Chun Yang;Daniel C. Bowers.
Lancet Oncology (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Institutes of Health
University of Miami
Indiana University
Kyoto University
University of Tokyo
Peking Union Medical College Hospital
Memorial Sloan Kettering Cancer Center
University of Utah
Emory University
Walter and Eliza Hall Institute of Medical Research
Google (United States)
Alibaba Group (China)
Wuhan University
National University of Singapore
Wolfspeed, Inc.
Beijing University of Chemical Technology
Hong Kong University of Science and Technology
Université Laval
University of Würzburg
Johannes Gutenberg University of Mainz
Heriot-Watt University
École des Ponts ParisTech
Stanford University
Inserm : Institut national de la santé et de la recherche médicale
Brigham and Women's Hospital
Maastricht University